Business Development

Pfizer R&D Campus Nears Completion

Courtesy of Pfizer & St. Louis County

The 295,000-Square-Foot Facility is in Chesterfield

Click here for a Facebook photo gallery

Pfizer Inc., one of the world’s premier biopharmaceutical companies, has broken ground on a state-of-the art Research and Development (R&D) and process development facility at 875 West Chesterfield Parkway in Chesterfield, Mo.

Photo Courtesy of Pfizer (2018)

The new campus will be owned by Pfizer and bring together more than 450 employees who currently work at multiple locations which the company leases in the St. Louis area. Pfizer expects to hire an additional 80 employees in the coming years to support research at the site. Construction is expected to be complete by mid-2019.

The facility will provide approximately 295,000 square feet of R&D space to house Pfizer’s BioTherapeutics Pharmaceutical Sciences group and enabling partners. This team is responsible for advancing Pfizer’s biologics, vaccines and gene therapy portfolio by developing manufacturing processes and dosage forms applying state-of-the-art analytical technologies, conducting non-GMP manufacturing and scale-up studies.

This critical work enables the development of potential new medicines to treat ailments in oncology, rare disease, internal medicine, inflammation & immunology and vaccines, including biosimilars.

“We’ve been proud to call Missouri home since 2002,” Pfizer Senior Vice President of BioTherapeutics Pharmaceutical Sciences John Ludwig said. “During this time, we’ve benefitted from the excellent life sciences workforce based in Missouri, and also from a strong partnership with the state, St. Louis County and St. Louis Economic Development Partnership. All of these were important factors as we sought a new home where we could continue to evolve our business over the coming years.”

“This is an important project that will create good-paying jobs for Missourians,” Missouri Governor Eric Greitens said. “We’re proud that Pfizer is investing and growing in Missouri.”

“There was a lot of competition for this facility,” St. Louis County Executive Steve Stenger said. “It makes sense an innovative company like Pfizer — that is at the forefront of its industry — recognizes the advantages of expanding in St. Louis County. I think that is a testament to our business-friendly climate and the quality of our workforce in St. Louis County. Our workers are well-educated and tech savvy. They are ready to do the important work that will be done here to save lives around the world.”

As part of the strategic incentives package from St. Louis County and the State of Missouri, Pfizer is donating $20,000 to the local Parkway School District to support STEM education.

New state-of-the-art features of the campus will include a floor plan which provides flexible laboratory layouts, scientific casework and utility hookups, open office and collaboration spaces and increased conferencing technologies where researchers can collaborate. CRG is providing design-build management services, partnering with Clayco as the design-builder. All architecture, landscape design, engineering, interior and lab/process design was provided by Forum and Ewing Cole.

The St. Louis site is an important part of Pfizer’s worldwide R&D network, which includes locations in La Jolla, Calif., Pearl River, N.Y., Groton, Conn., and Cambridge and Andover, Mass.


Pfizer Inc.: Working together for a healthier world

Pfizer applies science and our global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer healthcare products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world’s premier innovative biopharmaceutical companies, Pfizer collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.

For more than 150 years, Pfizer has worked to make a difference for all who rely on the company. It routinely posts information that may be important to investors at For more on social media, follow Pfizer on Twitter at @Pfizer and @Pfizer_News or like the company on Facebook at

Photo Courtesy of Pfizer (2018)